IAM
CC icon

Iridian Asset Management’s Chemours CC Stock Holding History

Iridian Asset Management’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-7,734,831
Closed -$287M – 76
2019
Q1 		$287M Sell
7,734,831
-1,961,261
-20% -$71.4M 3.66% 5
2018
Q4 		$274M Buy
9,696,092
+275,677
+3% +$8.72M 3.67% 4
2018
Q3 		$372M Buy
9,420,415
+2,439,293
+35% +$107M 3.72% 3
2018
Q2 		$310M Buy
6,981,122
+2,433,033
+53% +$121M 2.86% 7
2018
Q1 		$222M Buy
+4,548,089
New +$227M 1.99% 21

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Iridian Asset Management's CC Position: Q2 2019 in Review

Iridian Asset Management sold out of Chemours (CC) in Q2 2019, closing a stake of 7,734,831 shares — an estimated $287M sold.

Iridian Asset Management first reported a position in CC in Q1 2018 and held it in 5 quarters. The position peaked at $372M in Q3 2018. 488 funds tracked by Wall St. Rank hold CC as of Q2 2019.

  • Iridian Asset Management reported no remaining Chemours position as of Q2 2019 after selling out during the quarter.
  • Iridian Asset Management sold 7,734,831 Chemours shares in Q2 2019, an estimated $287M.
  • Iridian Asset Management first reported a position in Chemours in Q1 2018 and held it in 5 quarters.
  • Iridian Asset Management's Chemours position peaked at $372M in Q3 2018.
  • 488 funds tracked by Wall St. Rank held Chemours as of Q2 2019.

Based on Iridian Asset Management's 13F filing for Q2 2019, filed 31 Jul 2019.